Publication | Closed Access
Intrathecal administration of PNA targeting galanin receptor reduces galanin-mediated inhibitory effect in the rat spinal cord
42
Citations
18
References
2001
Year
Antisense ReagentPain MedicineMolecular BiologyMolecular PainExperimental PharmacologyUnmodified PnaIntrathecal AdministrationAntisense TherapyHealth SciencesSpinal Cord InjuryNeuropharmacologyNon-peptide LigandPharmacologyPain ResearchPeptide Nucleic AcidsPhysiologyNeuropeptide ReceptorNeuroscienceCentral Nervous SystemMedicineGalanin-mediated Inhibitory EffectGalanin ReceptorDrug DiscoveryNeuropeptides
Peptide nucleic acids (PNA) are nucleic acid analogues containing neutral amide backbone, forming stable and tight complexes with complementary DNA/RNA. However, it is unclear whether unmodified PNA can efficiently penetrate neuronal tissue in order to act as antisense reagent. Here we show that intrathecal (i.t.) injection of an unmodified antisense PNA complementary to the rat galanin receptor type 1 (GalR1) mRNA is able to block the inhibitory effect of i.t. administered galanin on spinal nociceptive transmission. Autoradiographic ligand binding studies using [125I]galanin show that the unmodified PNA is able to reduce the density of galanin binding sites in the dorsal horn. Thus, unmodified PNA applied i.t. appears to function as an effective antisense reagent in rat spinal cord in vivo.
| Year | Citations | |
|---|---|---|
Page 1
Page 1